A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 2, Pages 342-350
Publisher
Springer Nature
Online
2013-01-16
DOI
10.1038/bjc.2012.576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
- (2011) David Kaluza et al. EMBO JOURNAL
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- A work in progress: The clinical development of histone deacetylase inhibitor
- (2010) Silvia Marsoni et al. Epigenetics
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
- (2010) Kyle V. Butler et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis
- (2009) Susan Fotheringham et al. CANCER CELL
- Tubacin Kills Epstein-Barr Virus (EBV)-Burkitt Lymphoma Cells by Inducing Reactive Oxygen Species and EBV Lymphoblastoid Cells by Inducing Apoptosis
- (2009) Junichi Kawada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Function of Histone Deacetylase 6 as a Cofactor of Nuclear Receptor Coregulator LCoR
- (2009) Ana Palijan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- HDAC6 is a target for protection and regeneration following injury in the nervous system
- (2009) M. A. Rivieccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide
- (2009) Q.-D. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MCF-7 breast carcinoma cells do not express caspase-3
- (2008) Reiner U. Jänicke BREAST CANCER RESEARCH AND TREATMENT
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
- (2008) Y.-S. Lee et al. CANCER RESEARCH
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901
- (2008) J. Leyton et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- (2008) Aleksey G. Kazantsev et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation
- (2008) R. B. Parmigiani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2)
- (2007) David J. Witter et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started